Genomic medicine, gene replacement therapy, tissue engineering… all concepts that just a few years ago seemed like science fiction.
But for children affected by debilitating conditions and life-threatening diseases, Nationwide Children’s researchers are making these new therapies a health care reality. They seek answers on behalf of children everywhere, transforming the future of child health.
The Steve and Cindy Rasmussen Institute for Genomic Medicine combines a robust clinical laboratory with genome scientists and clinical geneticists to optimize patient care.
The Office of Technology Commercialization facilitates the transfer of innovations to external partners for the benefit of our community and the general public.
The mission of the Biopathology Center is to support cutting-edge research and positively impact patient care through procurement, processing, banking, and distribution of high-quality clinically-annotated biospecimens.
The cGMP Clinical Manufacturing Facility is located at Andelyn Biosciences, an affiliate company of Nationwide Children's Hospital.
Moving discoveries from bench to the best outcomes for children everywhere. The Abigail Wexner Research Institute at Nationwide Children’s Hospital enhances the health of children by engaging in high quality, cutting-edge research that results in better ways to prevent, screen for, diagnose
